APPLICATION OF AUTOLOGOUS PLATELET CONCENTRATES (PRP/PRF) IN ACNE SCAR REDUCTION AND THEIR ROLE IN IMPROVING PATIENTS’ PSYCHOSOCIAL QUALITY OF LIFE: A LITERATURE REVIEW
Authors:
- Julia MądrzakJMJulia Mądrzak
- Mikołaj MagierskiMMMikołaj Magierski
- Maciej MagierskiMMMaciej Magierski
- Weronika DudekWDWeronika Dudek
- Marcelina SkajewskaMSMarcelina Skajewska
- Julia StojkoJSJulia Stojko
- Oliwia DziewięCkaODOliwia DziewięCka
- Wojciech ZięBkaWZWojciech ZięBka
- Bartłomiej MarkowskiBMBartłomiej Markowski
Open Access
- 25 August 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Abstract
Background: Atrophic acne scars represent a prevalent dermatological challenge with significant cosmetic and psychosocial implications. While autologous platelet concentrates (APCs), such as platelet-rich plasma (PRP), are widely used to promote tissue repair, single-modality approaches often yield sub-optimal structural reconstruction in deep scarring. Objective: This review evaluates the biophysical mechanisms, release kinetics, and clinical efficacy of autologous platelet concentrates – specifically comparing classical PRP with advanced liquid platelet-rich fibrin (f-PRF/i-PRF) – both as monotherapy and within hybrid protocols combined with microneedling, subcision, and ablative fractional CO2 laser resurfacing. Methods: A comprehensive synthesis of current preclinical and clinical literature was conducted, analyzing the impact of centrifugation physics (relative centrifugal force, rotor geometry, chemical additives) on cellular viability and the structural remodeling cascade. Results: Liquid PRF modalities, prepared without exogenous anticoagulants, demonstrate superior biological kinetics compared to PRP, forming a three-dimensional bio-scaffold that enables sustained growth factor release (up to 10–14 days) and homogenous leukocyte migration. Clinical data unequivocally indicate that hybrid procedures outperform monotherapies. Synergizing physical interventions such as microneedling, CO2 laser resurfacing, or subcision with autologous cytokines markedly enhances neocollagenesis and extracellular matrix remodeling. Furthermore, combining APCs with physical modalities significantly reduces post-procedural erythema, edema, downtime, and the incidence of post-inflammatory hyperpigmentation. Conclusion: Advanced platelet-rich fibrin matrices represent a therapeutic evolution over traditional PRP, particularly in preventing fibrous re-anchoring during subcision and providing extended paracrine signaling. Establishing standardized centrifugation protocols and objective evaluation metrics remains essential to fully optimize APC-driven regenerative therapy in dermatological surgery.Keywords
This publication has 74 references indexed in Scilit:
- Platelet-rich plasma and ablative fractional carbon dioxide laser therapy for chronic scar management: a systematic reviewLasers in Medical Science, 2026
- Platelet-rich plasma as an adjuvant therapy to fractional ablative carbon dioxide lasers for cutaneous repair: a complementary treatment for atrophic acne scarringLasers in Medical Science, 2024
- Fluid Platelet-Rich Fibrin (PRF) Versus Platelet-Rich Plasma (PRP) in the Treatment of Atrophic Acne Scars: A Comparative StudyArchives of Dermatological Research, 2022
- Management of Acne VulgarisJAMA, 2021
- The effect of the anticoagulant on the cellular composition and growth factor content of platelet-rich plasmaCell and Tissue Banking, 2021
- A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugationJournal of Biomedical Materials Research Part A, 2019
- Injectable platelet rich fibrin: cell content, morphological, and protein characterizationClinical Oral Investigations, 2018
- Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?Clinical Oral Investigations, 2017
- Comparative release of growth factors from PRP, PRF, and advanced-PRFClinical Oral Investigations, 2016
- Quality of life of patients with keloid and hypertrophic scarringArchives of Dermatological Research, 2006